Regulation of cocaine reward by CREB.

Cocaine regulates the transcription factor CREB (adenosine 3', 5'-monophosphate response element binding protein) in rat nucleus accumbens, a brain region that is important for addiction. Overexpression of CREB in this region decreases the rewarding effects of cocaine and makes low doses of the drug aversive. Conversely, overexpression of a dominant-negative mutant CREB increases the rewarding effects of cocaine. Altered transcription of dynorphin likely contributes to these effects: Its expression is increased by overexpression of CREB and decreased by overexpression of mutant CREB. Moreover, blockade of kappa opioid receptors (on which dynorphin acts) antagonizes the negative effect of CREB on cocaine reward. These results identify an intracellular cascade-culminating in gene expression-through which exposure to cocaine modifies subsequent responsiveness to the drug.

[1]  M. Kuhar,et al.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine. , 1987, Science.

[2]  K. Berridge,et al.  The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.

[3]  T. Shippenberg,et al.  Sensitization to the Behavioral Effects of Cocaine: Modulation by Dynorphin and κ-Opioid Receptor Agonists , 1997, Pharmacology Biochemistry and Behavior.

[4]  A M Graybiel,et al.  A family of cAMP-binding proteins that directly activate Rap1. , 1998, Science.

[5]  R. Spanagel,et al.  Modulation of morphine-induced sensitization by endogenous κ opioid systems in the rat , 1993, Neuroscience Letters.

[6]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[7]  T. Joh,et al.  5' upstream DNA sequence of the rat tyrosine hydroxylase gene directs high-level and tissue-specific expression to catecholaminergic neurons in the central nervous system of transgenic mice. , 1994, Brain research. Molecular brain research.

[8]  M. Herkenham,et al.  Molecular alterations in the neostriatum of human cocaine addicts , 1993, Synapse.

[9]  C. Gerfen,et al.  Dynorphin opioid inhibition of cocaine‐induced, D1 dopamine receptor‐mediated immediatem‐early gene expression in the striatum , 1995, The Journal of comparative neurology.

[10]  E. Nestler,et al.  Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  G. Di Chiara,et al.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[12]  E. Nestler,et al.  A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function , 1991, Brain Research.

[13]  S. Hyman,et al.  Neuronal adaptation to amphetamine and dopamine: Molecular mechanisms of prodynorphin gene regulation in rat striatum , 1995, Neuron.

[14]  N. R. Richardson,et al.  Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. , 1991, Life sciences.

[15]  S. Hyman,et al.  Addiction to Cocaine and Amphetamine , 1996, Neuron.

[16]  G. Aghajanian,et al.  Molecular and cellular basis of addiction. , 1997, Science.

[17]  W. Gardner,et al.  Carcinogenesis , 1961, The Yale Journal of Biology and Medicine.

[18]  F. J. White,et al.  Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. , 1997, The Journal of pharmacology and experimental therapeutics.

[19]  E. Bartlett,et al.  Selective Sensitization to the Psychosis-Inducing Effects of Cocaine: A Possible Marker for Addiction Relapse Vulnerability? , 1997, Neuropsychopharmacology.

[20]  M. Montminy,et al.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.

[21]  S. Turgeon,et al.  Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization , 1997, Brain Research.

[22]  R. Spanagel,et al.  The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study , 1990, Journal of neurochemistry.

[23]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[24]  M. Kreek,et al.  Chronic repeated cocaine administration increases dopamine D1 receptor-mediated signal transduction. , 1996, European journal of pharmacology.

[25]  C. Gerfen,et al.  Cocaine self-administration differentially alters mRNA expression of striatal peptides. , 1992, Brain research. Molecular brain research.

[26]  B. Pitt.  Psychopharmacology , 1968, Mental Health.

[27]  R. Wise,et al.  Rewarding Actions of Phencyclidine and Related Drugs in Nucleus Accumbens Shell and Frontal Cortex , 1996, The Journal of Neuroscience.

[28]  T. Shippenberg,et al.  Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[29]  R. Kalb,et al.  Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus , 1997, Neuroscience.

[30]  P. Lang,et al.  Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. , 1996, BioTechniques.

[31]  R. Christopher Pierce,et al.  A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants , 1997, Brain Research Reviews.

[32]  Amtliches Mitteilungsblatt,et al.  August , 1890, The Hospital.

[33]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.